Cetampril

Quick links to important sections

Cetampril

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cetampril

Property Description
Active ingredient Enalapril maleate
Form Tablet (Oral preparation)
Pharmacological class Angiotensin-Converting Enzyme (ACE) inhibitors
General purpose Supports circulatory function by managing blood pressure
Origin Synthetic compound

What Type of Medicine is Cetampril?

Cetampril is a prescription-only medication that contains the active substance Enalapril maleate and belongs to the Angiotensin-Converting Enzyme (ACE) inhibitors class of drugs. Its primary function is to support the cardiovascular system by managing blood pressure. This class of medication is used in addressing hypertension and related heart conditions. The medication is designed to address conditions affecting the heart and blood circulation, specifically for adult patients. Enalapril maleate is an established compound within its class.


Cetampril's Composition and Physical Form

The core of Cetampril is the active ingredient, Enalapril maleate, which is typically administered as a solid oral preparation, specifically a tablet. Chemically, Enalapril is defined as a prodrug, which means the molecule itself is initially inactive when ingested but is converted by the body's metabolic processes into its therapeutically active substance, Enalaprilat, after absorption. The active ingredient belongs to a group of synthetic compounds used in cardiovascular treatment. The final formulation of the tablet is a single-ingredient product, which offers flexibility, and this preparation is solely for the oral route of administration.


What is the General Purpose of ACE Inhibitors?

The general purpose of the ACE inhibitor class, including the medication containing Enalapril maleate, is to help maintain proper circulatory function by regulating blood pressure. This class achieves its general benefit by promoting vasodilation, which is the relaxation and widening of blood vessels. By reducing the overall tension and systemic vascular resistance in the circulatory system, the medication lessens the burden placed upon the heart, thereby supporting its function. A typical application is the long-term management of high blood pressure, contributing to circulatory stability over time.

Regulatory References

  1. MedlinePlus ACE inhibitors article
  2. FDA label for Enalapril Maleate

What side effects are possible with Cetampril?

Possible Side Effects and Safety Information

The safety profile of Cetampril (Enalapril maleate) is established through official regulatory classification of adverse reactions, which are grouped by frequency and the physiological systems affected. Reactions are formally classified according to standardized frameworks used by health authorities.

Adverse Reaction Classifications

Side effects documented in regulatory labeling are grouped by frequency. Very common reactions (occurring in 1 out of 10 people or more) typically include dizziness, cough, nausea, and fatigue/asthenia. Reactions classified as Common include headache, hypotension (low blood pressure), and increases in serum creatinine or potassium levels.

Adverse reactions are also categorized by the System-Organ-Class (SOC) they affect, encompassing the Vascular, Respiratory, Nervous, Cardiac, Gastrointestinal, and Renal systems.

Serious Safety Considerations

Official documents highlight certain serious adverse reactions. The most notable is Angioedema, a rapid swelling of the face, extremities, or airway which can occur at any time during treatment. Other serious documented risks include acute renal failure, hepatic failure, and blood disorders like agranulocytosis.

Population-Specific Constraints

Regulatory labels define specific safety constraints for certain patient groups. Use during the second and third trimesters of pregnancy is strictly contraindicated due to the risk of fetal injury. The medicine is also contraindicated for patients with a documented history of Angioedema related to prior ACE inhibitor use and for those with specific severe forms of renal impairment or when co-administered with Aliskiren in diabetic patients. Hypotension is noted as being more likely after the initial dose in high-risk patients.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with the active substance Enalapril maleate can lead to serious and potentially life-threatening physiological events. The primary manifestation of an overdose is Severe Hypotension, characterized by a profound drop in blood pressure. Clinical signs that may accompany this include Dizziness, Faintness, and Sleepiness (Somnolence). Cardiovascular responses such as Tachycardia (rapid heartbeat) or Bradycardia (slow heartbeat) are also officially documented effects.


Mandated Emergency Actions

It is critical to seek immediate medical attention for any suspected overdose. Regulator-documented severe outcomes that necessitate urgent care include Acute Renal Failure, severe Hyperkalemia (high serum potassium), and Shock. Immediate hospitalization may be required for continuous monitoring and management of these serious complications.


Management Procedures

Regulatory information confirms that there is no specific antidote available for Cetampril overdose. Management focuses on supportive and symptomatic treatment. Procedures described in official documents include the infusion of Intravenous Saline for volume expansion to counteract hypotension and placing the patient in the Supine Position. Furthermore, Hemodialysis is a documented procedure, as the active metabolite, Enalaprilat, is dialyzable and can be removed from the system. Overdose management is especially critical for patients with pre-existing Renal Impairment due to the reduced clearance of the active substance.

Therapeutic Uses of Cetampril

What Cetampril Treats: Main Uses and Benefits

Cetampril is applied across domains where additional symptomatic support is needed in situations where patients experience symptoms that interfere with daily functioning. Its primary function is not curative, but rather to provide supportive therapeutic benefit during periods of acute distress or functional strain. Medicines in this therapeutic class are commonly used across conditions presenting with symptoms related to systemic imbalance.

Managing Acute Symptom Escalation

Cetampril is applied in settings marked by heightened patient distress and often used during phases when symptoms become more noticeable. It helps address symptom clusters that may become intense or disruptive, applying when short-term symptomatic assistance is needed. The medication may help patients cope more steadily with symptom fluctuations, providing supportive relief when manifestations become temporarily overwhelming.

Cetampril is commonly used to help with conditions characterized by periods of heightened symptoms, conditions involving episodic or fluctuating manifestations, and scenarios where additional management of discomfort is required.

“This medication is applied across domains where additional symptomatic support is needed, helping to ease the overall symptom load.”

Easing Functional Symptom Burden

This medication is applicable in conditions characterized by episodic or fluctuating symptom patterns, particularly when symptoms create noticeable interference with daily stability. Cetampril is commonly used to help address symptoms that create noticeable functional strain. It contributes to improved day-to-day comfort, assisting with maintaining functional stability during symptomatic periods.

Quick Fact: Relevant for Symptoms that Interfere with Daily Functioning

Regulatory References

  1. ACE inhibitors: MedlinePlus Medical Encyclopedia

Eligibility and Restrictions for Use

Cetampril is an Angiotensin-Converting Enzyme (ACE) inhibitor whose eligibility is strictly defined by government regulatory documents, outlining who is allowed, restricted, or prohibited from use.

Populations for Whom Use is Contraindicated

Absolute non-eligibility applies to patients with a history of angioedema related to previous ACE inhibitor treatment or those with hereditary or idiopathic angioedema. Use is also strictly contraindicated during the second and third trimesters of pregnancy due to the risk of fetal injury, requiring immediate discontinuation upon detection of pregnancy.

The medicine must not be used with sacubitril/valsartan (Neprilysin inhibitors) and is prohibited with aliskiren in patients with diabetes mellitus or significant renal impairment.

Age and Condition-Based Restrictions

Population Group Eligibility Status (Regulatory Wording)
Pediatrics Not recommended for neonates (infants mathbf1 month of age or less) or for children with severe renal impairment (GFR < 30 mL/min/1.73 m^2).
Organ Function Caution is warranted in patients with hepatic impairment. Use requires initial adjustment and close monitoring in patients with impaired renal function (creatinine clearance leq 30 mL/min).
Lactation Advised not to breastfeed due to potential risk to the infant.

Eligibility is limited by comorbidities like collagen vascular disease or severe aortic stenosis, where use requires careful clinical supervision.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cetampril (Enalapril maleate) has officially documented interaction patterns that result in mandatory restrictions, contraindications, and specific concentration changes when co-administered with certain substances. All interaction information is based on authoritative government regulatory documents.


Official Restrictions and Contraindications

Co-administration with Sacubitril/Valsartan is strictly contraindicated due to the significantly increased risk of angioedema. A mandatory 36-hour separation is required when switching between these medications. The combination with Aliskiren is also contraindicated in patients with diabetes mellitus or those with renal impairment (GFR < 60 mL/min/1.73 m²).

Procedural constraints apply to dialysis involving high-flux membranes or LDL apheresis with a Protein A column, both of which are contraindicated and require Cetampril to be discontinued 72 hours prior to the procedure.


Documented Pharmacodynamic and Exposure Effects

Interactions with Potassium-sparing Diuretics and Potassium Supplements result in an additive effect that increases the risk of hyperkalemia. This hyperkalemic risk is heightened in the elderly or those with renal impairment. The co-administration of Nonsteroidal Anti-inflammatory Drugs (NSAIDs) may result in renal function deterioration, which is a significant concern in volume-depleted individuals. Cetampril formally reduces the clearance of Lithium, leading to increased serum concentrations and subsequent risk of toxicity. The absorption of Cetampril is not officially influenced by the presence of food.

Mechanism of Action

How Cetampril Works: Pharmacodynamic Mechanism

Cetampril operates by targeted competitive inhibition of the Angiotensin-Converting Enzyme (ACE), an enzyme predominantly found on the surface of vascular endothelial cells.

This interaction blocks the conversion of Angiotensin I into the active peptide Angiotensin II, the primary mediator of the Renin-Angiotensin-Aldosterone System (RAAS). This suppression of Angiotensin II formation initiates the main molecular cascade, leading to a decrease in its systemic concentration.

As a consequence, Cetampril mediates a shift in the balance of vasoactive substances. It reduces Angiotensin II-mediated vasoconstriction and simultaneously reduces the enzymatic degradation of the naturally relaxing peptide Bradykinin. This dual modulation influences core mechanisms underlying Systemic Vascular Resistance (SVR), mediating a decrease in vascular tone in peripheral pathways. Furthermore, the reduction in Angiotensin II consequentially decreases Aldosterone secretion, thereby influencing sodium and water handling processes within renal pathways.

Dosage and Administration Information

Cetampril (Enalapril maleate) is administered via the oral route, available as tablets in strengths of 2.5 mg, 5 mg, 10 mg, and 20 mg. The clinical use of the drug's class also involves an intravenous (IV) route for the active metabolite, Enalaprilat, when oral intake is not feasible.


Standard Administration Protocol

The usage of Cetampril is characterized by a titration schedule, where therapy begins with a low starting dose and is gradually increased to the long-term maintenance dose, often over a period of days or weeks. For the management of hypertension, the initial dose is typically 5 mg once daily, while for symptomatic heart failure, the initial dose is 2.5 mg taken twice daily. The maximum recommended daily dose for all indications is 40 mg. Dosing frequency is either once daily or in divided twice-daily doses, depending on the condition and the duration of the drug's effect.


Key Contextual Instructions

Cetampril tablets may be taken with or without food as the drug's absorption is not affected by meals. The label provides specific instructions for dose modification in certain populations and contexts. For example, the initial oral dose is reduced to 2.5 mg once daily if a patient has moderately to severely impaired kidney function (Creatinine Clearance le 30 mL/min) or if they are concomitantly receiving a diuretic. In the event a dose is missed, common practice involves skipping the dose if it is close to the time of the next scheduled dose; doubling the dose to compensate is avoided.

Recent Clinical Evidence

Cetampril: Recent Clinical Evidence

Research on Cetampril (Enalapril maleate) focuses on its role as an Angiotensin-Converting Enzyme (ACE) inhibitor to support circulatory function by managing blood pressure. The evidence base primarily consists of Randomized Controlled Trials (RCTs) and meta-analyses that monitor changes in cardiovascular function and related outcomes.


Evidence for Use in High Blood Pressure (Hypertension)

Studies monitored measurements of systolic and diastolic blood pressure change in adult populations. The findings describe patterns of change in blood pressure measurements that were observed across various adult populations, with the duration of the measured change monitored over a 24-hour cycle. Research also examined whether there were changes in the frequency of major cardiovascular event occurrence.

Evidence for Use in Symptomatic Heart Failure

Large-scale, long-term RCTs observed the medication, often used in combination with other treatments. These studies evaluated whether there were changes in overall survival rates and the frequency of hospitalization related to heart failure. Research examined whether there were changes in functional ability and patient-reported outcomes describing perceived discomfort in patients with conditions characterized by fluctuating manifestations.


Long-Term Research and Limitations

Research has explored the role of Cetampril in patients with asymptomatic Left Ventricular Dysfunction, monitoring the rate of progression to symptomatic heart failure over extended periods. While long-term effects are not fully established for all specific endpoints and subgroups, studies were evaluated in up to five years or more.

In specific areas, such as its use in very young children or infants, research sample sizes were modest, and data for certain groups remain insufficient. Comparative evidence is also limited for some newer subgroups, meaning research is ongoing.

Key Studies & References Angiotensin-Converting Enzyme (ACE) inhibitors (Patient Instructions)

Frequently Asked Questions (FAQ)

Common questions about Cetampril (FAQ)

Q: How quickly should I expect Cetampril to start working?

A: Authoritative information suggests the medication may begin the process of reducing blood pressure within a few hours of the first dose. However, the full beneficial effect of the medication may take a few weeks to be fully established, or longer if it is being used to support conditions like heart failure.

Q: Is it normal to feel a little dizzy when starting Cetampril?

A: Dizziness is officially classified as a Very Common side effect. Official guidance notes that feeling dizzy or lightheaded is more likely to occur after the initial dose in certain high-risk patients. The occurrence of this effect is noted in the drug's official safety profile.

Q: What are the official recommendations for using Cetampril during pregnancy?

A: Use of this medication is strictly contraindicated (not allowed) during the second and third trimesters of pregnancy due to the risk of fetal injury. For the first trimester, official guidance advises discontinuation as soon as pregnancy is detected. Consultation for pre-conception planning is a common element of care noted in official guidance.

Q: Is it safe to take Cetampril if you also take pain relievers like ibuprofen?

A: Official regulatory information notes that co-administration with Nonsteroidal Anti-inflammatory Drugs (NSAIDs), which includes ibuprofen, is documented as potentially resulting in renal (kidney) function deterioration. This possibility is a specific safety concern noted in the label, particularly for elderly or volume-depleted individuals.

Q: Does Cetampril change how other medicines work in the body?

A: Official regulatory documents indicate that Cetampril has documented interaction patterns with other medicines. These interactions may result in an additive effect, such as increasing the risk of high blood potassium, or changing the serum concentration of other drugs, such as Lithium.

Q: Can men who take Cetampril have issues with sexual function?

A: Sexual dysfunction is not typically listed as a Very Common or Common adverse reaction in the official regulatory labels. Furthermore, authoritative patient information does not detail evidence of reduced fertility for men or women.

Q: How does the time of day you take Cetampril affect its action?

A: The medicine can generally be taken at any time of day, as the drug's absorption is not affected by food. The dosing schedule is defined as either once daily or in divided twice-daily doses, depending on the medical condition that is being treated.

Q: What happens if you suddenly stop taking Cetampril?

A: Abrupt discontinuation of Cetampril is not officially associated with a rapid, acute increase in blood pressure. However, as the medication is intended for long-term management of circulatory issues, official information states that stopping the medication may be associated with the return of previously controlled blood pressure or heart condition symptoms.

Q: Why do some people need to take Cetampril alongside a diuretic (water pill)?

A: Official documents explain that the diuretic helps to reduce the amount of water in the body, which complements Cetampril’s action as an ACE inhibitor. Together, they promote the relaxation of blood vessels and are used in combination to manage blood pressure.

Q: Does Cetampril require a special diet to work properly?

A: While the drug’s absorption is not affected by meals, the official label notes that this class of drug increases the risk of high blood potassium (hyperkalemia). For this reason, official guidance mentions that use of salt substitutes that contain potassium chloride should be reviewed with a healthcare provider due to the potential risk of hyperkalemia.

Q: Are there different doses of Cetampril, and what do they mean?

A: The different strengths (e.g., 2.5 mg, 5 mg, etc.) allow for a titration schedule. A healthcare provider uses a lower dose initially and gradually increases it to establish the appropriate long-term maintenance dose for the patient and the specific condition.

Q: Does Cetampril contain sulfa or penicillin?

A: The active ingredient, Enalapril maleate, is a synthetic compound. Chemical analysis confirms that its structure does not contain a sulfa group or a penicillin structure.

Q: Is it possible for Cetampril to cause a persistent dry cough?

A: Cough is listed as a Very Common reaction in official documents. This cough is generally described as a dry, non-productive type which may resolve if treatment with this class of drug is stopped.

Q: Can taking Cetampril affect laboratory blood test results?

A: Yes, regulatory documents describe that the medication can increase the serum levels of creatinine and potassium. Regulatory documents state that healthcare providers typically monitor these blood tests during the course of therapy.

Q: Is Cetampril ever prescribed for conditions other than high blood pressure?

A: Yes, in addition to managing high blood pressure, the drug is officially approved for lowering the risk of hospitalization and death related to symptomatic heart failure. It is also approved for treating patients with asymptomatic Left Ventricular Dysfunction.

Q: Does Cetampril have a generic version available?

A: Yes, regulatory bodies like the FDA have approved generic versions of the active ingredient, Enalapril maleate. Availability of the generic version may depend on the local market and pharmacy.

Q: What is the half-life of Cetampril in the body?

A: Pharmacokinetic data from the official label indicates that the effective half-life of the active substance, Enalaprilat, following multiple oral doses is approximately 11 hours. This refers to the time it takes for half of the drug to be eliminated from the body.

Q: Is Cetampril considered safe for patients with liver problems?

A: Official documents state that caution is warranted in patients who have hepatic impairment (liver problems). While an initial dosage adjustment is often not required, the label requires close clinical monitoring for patients with this condition.

Q: Is it true that Cetampril is not recommended for African American patients?

A: Official regulatory documents note that while the medication was observed to be antihypertensive in all races studied, Black hypertensive patients generally demonstrated a smaller average response to the drug when used as monotherapy compared to non-Black patients.

Q: Is Cetampril the same drug as Lisinopril or Ramipril?

A: No, the active ingredient in Cetampril is Enalapril maleate. Lisinopril and Ramipril are separate, distinct active substances that belong to the same pharmacological class of medication: the ACE inhibitors.

Q: What is the maximum dose of Cetampril allowed according to the FDA?

A: According to the Dosage and Administration section of the FDA label, the maximum recommended oral daily dose for adults for all approved indications is 40 mg.

How should Cetampril be stored and disposed of?

Official Storage and Disposal Instructions for Cetampril

Cetampril (enalapril maleate) tablets must be stored at Controlled Room Temperature (CRT), specifically between 20 C to 25 C (68 F to 77 F). The product is required to be protected from moisture and must be kept in a tightly closed container or its original container.


Required Handling and Safety

  • The medication must be stored out of the sight and reach of children to prevent accidental ingestion.
  • Disposal of any unused or expired tablets should follow instructions from a healthcare professional or a local take-back program.
  • Regulatory guidelines specify that the medicine should not be disposed of in household trash or poured into wastewater, aligning with environmental protection standards for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cetampril found in:

A-Z Index: